Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Last €2.36 EUR
Change Today -0.02 / -0.84%
Volume 419.3K
As of 11:38 AM 02/11/16 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Avenida Autonomía, 10


Bilbao, 48940


Phone: 34 94 481 83 00

Fax: 34 94 481 83 01

Faes Farma, S.A. engages in the research, development, manufacture, market, and sale of pharmaceutical products; and raw materials for pharmaceutical use worldwide. The company offers prescription, OTC, and skin-care treatment products. It provides cardiovascular products, such as Drosmina, Hyflon, Venosmil, Venosmil Gel, and Venula; central nervous system products, including Colme, Surmenalit, and Trausan; dermatology products comprising Positón; digestive products, such as Mecolzine; metabolism products, including Dynamogen, Ferroprotina, and Potenciator; Locomotor products comprising Defal, Distem, Dolotren, and Dolotren gel; Bilaxten and Bilidren for allergy; and respiratory products, such as Bronquidiazina CR and Yendol. The company also offers raw materials, including diosmin, hidrosmin, magnesium pidolate, arginine aspartate, granulated diosmin, glutodine, trimethropim, and pyrrolidone carboxylate. In addition, it develops Bilastine, an antihistamine, which is in Phase III clinical trials; F-97013-GD, an atypical antipsychotic that is in pre-clinical phase; F-98214-TA, an antidepressant, which is in pre-clinical phase; and serotonin reuptake inhibitors. Faes Farma, S.A. was founded in 1933 and is headquartered in Bilbao, Spain.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FAE:SM €2.36 EUR -0.02

FAE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Recordati SpA €20.48 EUR +0.17
Shire PLC 3,507 GBp -61.00
Procter & Gamble Co/The $79.90 USD -1.72
View Industry Companies

Industry Analysis


Industry Average

Valuation FAE Industry Range
Price/Earnings 20.6x
Price/Sales 2.8x
Price/Book 2.4x
Price/Cash Flow 18.4x
TEV/Sales 2.8x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact FAES FARMA SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at